FIRST TRUST ADVISORS LP - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 238 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$330,881
-91.2%
33,355
-89.6%
0.00%
-100.0%
Q1 2024$3,765,689
+128.3%
319,668
+175.0%
0.00%
+100.0%
Q4 2023$1,649,530
-58.0%
116,246
-64.0%
0.00%
-60.0%
Q3 2023$3,923,861
+2969.5%
322,686
+3070.4%
0.01%
Q2 2023$127,835
-94.4%
10,178
-95.1%
0.00%
-100.0%
Q1 2023$2,287,523
-13.3%
206,269
-4.5%
0.00%0.0%
Q4 2022$2,637,946
-11.7%
216,048
-24.5%
0.00%
-25.0%
Q3 2022$2,986,000
+106.9%
285,983
+112.9%
0.00%
+100.0%
Q2 2022$1,443,000
+23.2%
134,352
+8.6%
0.00%
+100.0%
Q1 2022$1,171,000
-39.8%
123,692
-26.6%
0.00%
-50.0%
Q4 2021$1,945,000
-31.7%
168,428
-41.6%
0.00%
-33.3%
Q1 2021$2,848,000
-54.2%
288,291
+7.0%
0.00%
-62.5%
Q4 2020$6,220,000
+162.9%
269,364
+60.8%
0.01%
+100.0%
Q3 2020$2,366,000
-7.7%
167,550
-1.5%
0.00%0.0%
Q2 2020$2,564,000
+119.9%
170,038
+34.8%
0.00%
+33.3%
Q1 2020$1,166,000
+682.6%
126,148
+724.0%
0.00%
Q4 2019$149,000
-81.6%
15,310
-84.8%
0.00%
-100.0%
Q3 2019$808,000
-73.5%
100,698
-58.8%
0.00%
-66.7%
Q2 2019$3,052,000
+380.6%
244,550
+424.0%
0.01%
+500.0%
Q1 2019$635,000
-75.4%
46,670
-78.1%
0.00%
-80.0%
Q3 2018$2,580,000
-10.4%
213,396
+15.8%
0.01%
-16.7%
Q2 2018$2,880,000
+17.6%
184,350
+13.2%
0.01%0.0%
Q1 2018$2,450,000162,8670.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 9,029,843$89,576,04310.38%
Perceptive Advisors 28,057,456$278,329,9646.70%
Redmile Group, LLC 10,595,089$105,103,2836.36%
STEMPOINT CAPITAL LP 1,495,047$14,830,8664.36%
CM Management, LLC 450,000$4,464,0004.10%
Avoro Capital Advisors LLC 27,400,000$271,808,0003.62%
GREAT POINT PARTNERS LLC 1,495,500$14,835,3602.84%
Saturn V Capital Management LP 713,536$7,078,2772.68%
AlphaCentric Advisors LLC 202,500$2,008,8001.48%
Novo Holdings A/S 2,500,000$24,800,0001.44%
View complete list of AMICUS THERAPEUTICS INC shareholders